| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 1355-1360, Copyright © 1995 by Endocrine Society
ARTICLES |
JF Martini, SM Villares, M Nagano, MC Delehaye-Zervas, B Eymard, PA Kelly and MC Postel-Vinay
INSERM U-344, Endocrinologie Moleculaire, Necker-Enfants Malades, Paris, France.
A single form of GH receptor (GHR) messenger RNA (mRNA) of 4.5 kilobases, encoding the full-length GHR, has been found in man. To measure the absolute number of mRNA molecules encoding the GHR in human tissues, we developed a quantitative polymerase chain reaction assay. An internal control RNA was constructed by inserting a 50-basepair fragment of the rat PRL receptor complementary DNA into a portion of the human GHR complementary DNA. The internal control RNA and the target mRNA were amplified together with the same set of primers. Twenty-four cycles of amplification were used to satisfy an exponential phase of amplification. It was possible to detect as few as 500 molecules of target mRNA/micrograms total RNA. In 3 liver samples obtained from normal donors at the time of transplant, the amount of GHR mRNA ranged from 0.5 +/- 0.1 to 1.4 +/- 0.4 x 10(6) molecules/micrograms total RNA. These results were confirmed by slot blot analysis of the same samples. The number of receptor transcripts did not appear to be correlated with the receptor-binding capacity found in the 3 liver samples. In 7 muscle biopsies, GH receptor mRNA varied between 4.0 +/- 0.4 and 34.6 +/- 1.4 x 10(4) molecules/micrograms total RNA. This technique allows direct measurement of GHR gene expression in human tissues and represents a valuable tool, particularly for tissues such as muscle, in which the receptor protein cannot be measured using conventional binding assays.
This article has been cited by other articles:
![]() |
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults Endocr. Rev., May 1, 2006; 27(3): 287 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ballesteros, K.-C. Leung, R. J. M. Ross, T. P. Iismaa, and K. K. Y. Ho Distribution and Abundance of Messenger Ribonucleic Acid for Growth Hormone Receptor Isoforms in Human Tissues J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2865 - 2871. [Abstract] [Full Text] |
||||
![]() |
E. S. Shen, E. H. Meade, M. C. Perez, D. C. Deecher, A. Negro-Vilar, and F. J. Lopez Expression of Functional Estrogen Receptors and Galanin Messenger Ribonucleic Acid in Immortalized Luteinizing Hormone-Releasing Hormone Neurons: Estrogenic Control of Galanin Gene Expression Endocrinology, March 1, 1998; 139(3): 939 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Touraine, J.-F. Martini, B. Zafrani, J.-C. Durand, F. Labaille, C. Malet, A. Nicolas, C. Trivin, M.-C. Postel-Vinay, F. Kuttenn, et al. Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 667 - 674. [Abstract] [Full Text] |
||||
![]() |
M. Jinno, Y. Katsumata, T. Hoshiai, Y. Nakamura, K. Matsumoto, and Y. Yoshimura A Therapeutic Role of Prolactin Supplementation in Ovarian Stimulation for in Vitro Fertilization: The Bromocriptine-Rebound Method J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3603 - 3611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lin, B. B. Mendonca, A. M. Lucon, I. C. de Mello Guazzelli, W. Nicolau, and S. M. F. Villares Growth Hormone Receptor Messenger Ribonucleic Acid in Normal and Pathologic Human Adrenocortical Tissues--An Analysis by Quantitative Polymerase Chain Reaction Technique J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2671 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hermansson, R. B. Wickelgren, F. Hammarqvist, R. Bjarnason, I. Wennstrom, J. Wernerman, B. Carlsson, and L. M. S. Carlsson Measurement of Human Growth Hormone Receptor Messenger Ribonucleic Acid by a Quantitative Polymerase Chain Reaction-Based Assay: Demonstration of Reduced Expression after Elective Surgery J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 421 - 428. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |